CPH.AX - Creso Pharma Limited

ASX - ASX Delayed price. Currency in AUD
0.2650
0.0000 (0.00%)
At close: 3:54PM AEDT
Stock chart is not supported by your current browser
Previous close0.2650
Open0.2650
Bid0.2600 x 0
Ask0.2650 x 0
Day's range0.2500 - 0.2650
52-week range0.2500 - 0.5900
Volume533,997
Avg. volume174,761
Market cap40.159M
Beta (3Y monthly)3.22
PE ratio (TTM)N/A
EPS (TTM)-0.1110
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Why this ASX cannabis share price is in limbo today
    Motley Fool

    Why this ASX cannabis share price is in limbo today

    Trading in shares of Althea Group Holdings Ltd (ASX: AGH) has been halted amid reports that a major shareholder and supplier is heading for the door.The post Why this ASX cannabis share price is in limbo today appeared first on Motley Fool Australia.

  • The cannabis collapse: ASX marijuana shares going cheap
    Motley Fool

    The cannabis collapse: ASX marijuana shares going cheap

    Investors have pulled back from marijuana shares as the sector begins to mature and the adverse publicity surrounding vaping takes its toll. But has the sell down been overdone?The post The cannabis collapse: ASX marijuana shares going cheap appeared first on Motley Fool Australia.

  • Why these ASX cannabis shares are being smoked
    Motley Fool

    Why these ASX cannabis shares are being smoked

    The AusCann Group Holdings Ltd (ASX:AC8) share price is one of three in the cannabis industry hitting a 52-week low...The post Why these ASX cannabis shares are being smoked appeared first on Motley Fool Australia.

  • Why BWX, Creso Pharma, Mayne Pharma, & St Barbara shares dropped lower
    Motley Fool

    Why BWX, Creso Pharma, Mayne Pharma, & St Barbara shares dropped lower

    The Mayne Pharma Group Ltd (ASX:MYX) share price and the St Barbara Ltd (ASX:SBM) share price are two of four ending the week deep in the red...

  • Why these ASX cannabis shares are on the move today
    Motley Fool

    Why these ASX cannabis shares are on the move today

    BOD Australia Ltd (ASX:BDA), Creso Pharma Limited (ASX:CPH), and MGC Pharmaceuticals Ltd (ASX:MXC) shares are on watch today after making announcements...

  • This ASX cannabis share could soon be taken over
    Motley Fool

    This ASX cannabis share could soon be taken over

    The Creso Pharma Ltd (ASX:CPH) share price remains suspended following the release of a takeover update...

  • ACN Newswire

    Creso Pharma Gears Up for Adult-Use Market with New Supply Agreement -- CFN Media

    SEATTLE, WA, Jan 24, 2019 - (ACN Newswire) - via NEWMEDIAWIRE -- CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma Ltd. (ASX:CPH.AX - News) and its unique position with near-term production, existing supply agreements, and an established European cannabidiol (CBD) line of products. Canada's cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of adult-use cannabis in October of last year. While many licensed producers have been scaling up their production, the market continues to experience a shortfall in supply that has created an opportunity for investors in companies with near-term production coming online.

  • ACN Newswire

    Creso Pharma Targets Multi-Billion Dollar Pet Industry -- CFN Media

    SEATTLE, WA, Jan 16, 2019 - (ACN Newswire) - via NEWMEDIAWIRE -- CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma Inc. (ASX:CPH.AX - News) and why it's well positioned to capitalize on the rapid growth in the pet CBD market. Global consumers spend billions of dollars on their pets each year, according to GfK, with two-thirds of sales taking place in the United States and Europe. In the U.S. alone, the American Pet Products Association reckons that consumers spent more than $72 billion on their pets in 2018, including about $30 billion on food, $15 billion on supplies and over-the-counter medicine, and $20 billion on veterinary care.

  • GlobeNewswire

    Creso Looks to Capitalize on Domestic & Foreign Legislation -- CFN Media

    SEATTLE, Jan. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma Inc. (ASX:CPH), new legislation, and how it aims to become one of the world’s most trusted suppliers of cannabis and hemp-derived products by combining pharmaceutical rigor, good manufacturing practices (GMP) standards, and proprietary delivery technologies. The cannabis industry is driven primarily by legislation—whether it’s the legalization of adult-use cannabis across a growing number of countries or more nuanced legal moves. Over the past few months, two pieces of legislation could have a significant impact on the global cannabis industry: The passage of the 2018 Farm Bill in the United States and the legalization of medical cannabis exports in Israel.

  • ACN Newswire

    Creso Pharma Brings Together Cannabis Experts Across Several Verticals -- CFN Media

    SEATTLE, WA, Dec 19, 2018 - (ACN Newswire) - via NEWMEDIAWIRE -- CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma Ltd. (ASX:CPH.AX - News), a small-cap company founded in 2016 that has amassed one of the most experienced management teams in the cannabis industry. Small-cap stocks tend to be earlier stage companies without an established earnings track record, which means that investors must consider the management team above all else. In this article, we will take a closer look at the company's management team and advisory board, as well as how their expertise have helped drive progress.

  • GlobeNewswire

    Creso Pharma Brings Together Cannabis Experts Across Several Verticals-- CFN Media

    CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma Ltd. (ASX:CPH), a small-cap company founded in 2016 that has amassed one of the most experienced management teams in the cannabis industry. Small-cap stocks tend to be earlier stage companies without an established earnings track record, which means that investors must consider the management team above all else. In this article, we will take a closer look at the company’s management team and advisory board, as well as how their expertise have helped drive progress.

  • ACN Newswire

    Creso Pharma: A Truly Global Cannabis Company -- CFN Media

    SEATTLE, WA, Dec 6, 2018 - (ACN Newswire) - via NEWMEDIAWIRE -- CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma's (ASX:CPH.AX - News) innovative approach, diverse product portfolio, and why investors may want to take a closer look as it gears up to go public on the Venture exchange in Canada. The listing would make Creso the first public cannabis company listed in both Australia and Canada. The North American cannabis industry is littered with companies touting global ambitions.

  • GlobeNewswire

    Creso Pharma: A Truly Global Cannabis Company-- CFN Media

    SEATTLE, Dec. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Creso Pharma’s (ASX:CPH) innovative approach, diverse product portfolio, and why investors may want to take a closer look as it gears up to go public on the Venture exchange in Canada. The listing would make Creso the first public cannabis company listed in both Australia and Canada. The North American cannabis industry is littered with companies touting global ambitions.